CV Sciences, Inc. SEC filings CVSI
CV Sciences, Inc. has 431 filings in SEC EDGAR's recent list, going back to Jan 31, 2011. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 15, 2026 | Apr 15, 2026 |
| DEF 14A | Proxy statement | Apr 15, 2025 | Apr 15, 2025 |
| DEF 14A | Proxy statement | Apr 12, 2024 | Apr 11, 2024 |
| DEF 14A | Proxy statement | Apr 11, 2023 | Apr 11, 2023 |
| DEF 14A | Proxy statement | Apr 15, 2022 | Apr 15, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2022 | Apr 4, 2022 |
| DEF 14A | Proxy statement | Apr 8, 2021 | Apr 8, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2021 | Mar 26, 2021 |
| DEF 14A | Proxy statement | Mar 26, 2021 | Mar 26, 2021 |
| DEFA14A | Additional proxy material | Jun 2, 2020 | — |
| DEF 14A | Proxy statement | Mar 31, 2020 | May 21, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2020 | May 21, 2020 |
| DEFA14A | Additional proxy material | Apr 30, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Apr 26, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2019 | Jun 11, 2019 |
| DEFA14A | Additional proxy material | Jun 26, 2018 | — |
| DEFA14A | Additional proxy material | Jun 25, 2018 | — |
| DEF 14A | Proxy statement | Jun 18, 2018 | Aug 4, 2018 |
| PRE 14A | Preliminary proxy statement | Jun 8, 2018 | Aug 4, 2018 |
| DEFA14A | Additional proxy material | Jun 2, 2017 | — |
| DEF 14A | Proxy statement | May 26, 2017 | Jul 14, 2017 |
| PRE 14A | Preliminary proxy statement | May 16, 2017 | Jul 14, 2017 |
| DEF 14A | Proxy statement | Sep 13, 2016 | Oct 24, 2016 |
| DEF 14A | Proxy statement | Nov 6, 2015 | Dec 21, 2015 |
| DEF 14A | Proxy statement | Aug 21, 2015 | Oct 9, 2015 |
| DEF 14A | Proxy statement | Jul 2, 2014 | Jul 23, 2014 |
| DEF 14A | Proxy statement | Jun 24, 2013 | Jul 25, 2013 |
| PRE 14A | Preliminary proxy statement | Jun 4, 2013 | Jun 4, 2013 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVSI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1510964
- Former names
- CannaVEST Corp. (until Jan 4, 2016); Foreclosure Solutions, Inc. (until Nov 30, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.